MBRX

Moleculin Biotech (MBRX)

About Moleculin Biotech (MBRX)

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. The company was founded by Walter V. Klemp, Donald H. Picker, and Waldemar Priebe in July 2015 and is headquartered in Houston, TX.

Details

Daily high

$4.06

Daily low

$3.75

Price at open

$3.86

52 Week High

$91.25

52 Week Low

$3.63

Market cap

8.1M

Dividend yield

0.00%

Volume

155,138

Avg. volume

653,088

P/E ratio

-.06

Moleculin Biotech News